ArticleHeliyon2022

The novel m6A writer METTL5 as prognostic biomarker probably associating with the regulation of immune microenvironment in kidney cancer.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.